biocon

[ad_1] Biocon Ltd is leading India’s push into weight loss drugs as patents for some of the blockbuster medications are set to expire. The pharma company has won approval from the UK regulator for the first generic version of liraglutide injectible, which is losing patent protection in November. Novo Nordisk’s weight loss drug, sold under the brand name Saxenda, is among the first anti-obesity medications to lose patent protection.…

[ad_1] Indian stock market today: A total of 7 stocks have been banned for trade on Friday, March 22, 2024, under the futures and options (F&O) segment by the National Stock Exchange (NSE). The securities have been put on ban under the F&O segment as they crossed 95% of the market-wide position limit (MWPL), according to the NSE. However, the stocks will be available for trading in the cash…